Company / Named in our posts
Liminatus Pharma, LLC.
Follow Liminatus Pharma, LLCLiminatus Pharma is a pre-clinical-stage, single-asset biopharmaceutical company developing cancer therapies that exploit the body’s immune system.[1]
01Deal
Deals on Carrywatch
Every deal that names Liminatus Pharma, LLC, and its role in each.
Iris Acquisition Corp / Liminatus Pharma, LLC
Iris Acquisition Corp completed its deal for Liminatus Pharma, LLC.
See deal detailsDeal Web
Liminatus Pharma, LLC and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
1 fiscal year of figures as Liminatus Pharma, LLC reported them.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01Exhibit 99.5
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming Liminatus Pharma, LLC:
- P01